Verge Genomics, which is developing treatments for ALS and Parkinson's, has raised series A funding from backers including WuXi AppTec.

HealthCap has backed sickle cell disease therapy developer Modus Therapeutics, joining existing shareholders such as Karolinska Development.

BlueCross BlueShield Venture Partners led care management platform Octave's series A round, which included Echo Health Ventures.

Professional and educational networking platform Goodwall has secured $10.8m in a round co-led by Randstad Innovation.

Alexandria Venture Investments and Biomed Realty Ventures were among the investors as the immunotherapy developer closed the round's final tranche.

Inra spinout Nextbiotix has attracted capital from the institute itself as well as Biocodex and other institutional investors.